199 related articles for article (PubMed ID: 24183476)
1. Novel SETX variants in a patient with ataxia, neuropathy, and oculomotor apraxia are associated with normal sensitivity to oxidative DNA damaging agents.
Vantaggiato C; Cantoni O; Guidarelli A; Romaniello R; Citterio A; Arrigoni F; Doneda C; Castelli M; Airoldi G; Bresolin N; Borgatti R; Bassi MT
Brain Dev; 2014 Sep; 36(8):682-9. PubMed ID: 24183476
[TBL] [Abstract][Full Text] [Related]
2. Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients.
Anheim M; Monga B; Fleury M; Charles P; Barbot C; Salih M; Delaunoy JP; Fritsch M; Arning L; Synofzik M; Schöls L; Sequeiros J; Goizet C; Marelli C; Le Ber I; Koht J; Gazulla J; De Bleecker J; Mukhtar M; Drouot N; Ali-Pacha L; Benhassine T; Chbicheb M; M'Zahem A; Hamri A; Chabrol B; Pouget J; Murphy R; Watanabe M; Coutinho P; Tazir M; Durr A; Brice A; Tranchant C; Koenig M
Brain; 2009 Oct; 132(Pt 10):2688-98. PubMed ID: 19696032
[TBL] [Abstract][Full Text] [Related]
3. SETX mutations are a frequent genetic cause of juvenile and adult onset cerebellar ataxia with neuropathy and elevated serum alpha-fetoprotein.
Nanetti L; Cavalieri S; Pensato V; Erbetta A; Pareyson D; Panzeri M; Zorzi G; Antozzi C; Moroni I; Gellera C; Brusco A; Mariotti C
Orphanet J Rare Dis; 2013 Aug; 8():123. PubMed ID: 23941260
[TBL] [Abstract][Full Text] [Related]
4. Ataxia with oculomotor apraxia type 2: a clinical and genetic study of 19 patients.
Tazir M; Ali-Pacha L; M'Zahem A; Delaunoy JP; Fritsch M; Nouioua S; Benhassine T; Assami S; Grid D; Vallat JM; Hamri A; Koenig M
J Neurol Sci; 2009 Mar; 278(1-2):77-81. PubMed ID: 19141356
[TBL] [Abstract][Full Text] [Related]
5. Characterization of two novel SETX mutations in AOA2 patients reveals aspects of the pathophysiological role of senataxin.
Airoldi G; Guidarelli A; Cantoni O; Panzeri C; Vantaggiato C; Bonato S; Grazia D'Angelo M; Falcone S; De Palma C; Tonelli A; Crimella C; Bondioni S; Bresolin N; Clementi E; Bassi MT
Neurogenetics; 2010 Feb; 11(1):91-100. PubMed ID: 19593598
[TBL] [Abstract][Full Text] [Related]
6. Clinical and molecular findings of ataxia with oculomotor apraxia type 2 (AOA2) in 5 Tunisian families.
Hammer MB; El Euch-Fayache G; Nehdi H; Saidi D; Nasri A; Nabli F; Bouhlal Y; Maamouri-Hicheri W; Hentati F; Amouri R
Diagn Mol Pathol; 2012 Dec; 21(4):241-5. PubMed ID: 23111195
[TBL] [Abstract][Full Text] [Related]
7. Ovarian failure in ataxia with oculomotor apraxia type 2.
Lynch DR; Braastad CD; Nagan N
Am J Med Genet A; 2007 Aug; 143A(15):1775-7. PubMed ID: 17593543
[TBL] [Abstract][Full Text] [Related]
8. A novel nonsense mutation in a Japanese family with ataxia with oculomotor apraxia type 2 (AOA2).
Nakamura K; Yoshida K; Makishita H; Kitamura E; Hashimoto S; Ikeda S
J Hum Genet; 2009 Dec; 54(12):746-8. PubMed ID: 19893583
[TBL] [Abstract][Full Text] [Related]
9. Clinical and molecular findings of ataxia with oculomotor apraxia type 2 in 4 families.
Anheim M; Fleury MC; Franques J; Moreira MC; Delaunoy JP; Stoppa-Lyonnet D; Koenig M; Tranchant C
Arch Neurol; 2008 Jul; 65(7):958-62. PubMed ID: 18625865
[TBL] [Abstract][Full Text] [Related]
10. Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study.
Criscuolo C; Chessa L; Di Giandomenico S; Mancini P; Saccà F; Grieco GS; Piane M; Barbieri F; De Michele G; Banfi S; Pierelli F; Rizzuto N; Santorelli FM; Gallosti L; Filla A; Casali C
Neurology; 2006 Apr; 66(8):1207-10. PubMed ID: 16636238
[TBL] [Abstract][Full Text] [Related]
11. Exon deletions and intragenic insertions are not rare in ataxia with oculomotor apraxia 2.
Bernard V; Minnerop M; Bürk K; Kreuz F; Gillessen-Kaesbach G; Zühlke C
BMC Med Genet; 2009 Sep; 10():87. PubMed ID: 19744353
[TBL] [Abstract][Full Text] [Related]
12. Ataxia with oculomotor apraxia type 2 caused by a novel homozygous mutation in SETX gene, and literature review.
Chen S; Du J; Jiang H; Zhao W; Wang N; Ying A; Li J; Chen S; Shen B; Zhou Y
Front Mol Neurosci; 2022; 15():1019974. PubMed ID: 36438189
[TBL] [Abstract][Full Text] [Related]
13. Ataxia with oculomotor apraxia type 2 fibroblasts exhibit increased susceptibility to oxidative DNA damage.
Roda RH; Rinaldi C; Singh R; Schindler AB; Blackstone C
J Clin Neurosci; 2014 Sep; 21(9):1627-31. PubMed ID: 24814856
[TBL] [Abstract][Full Text] [Related]
14. Clinical and molecular characterization of ataxia with oculomotor apraxia patients in Saudi Arabia.
Bohlega SA; Shinwari JM; Al Sharif LJ; Khalil DS; Alkhairallah TS; Al Tassan NA
BMC Med Genet; 2011 Feb; 12():27. PubMed ID: 21324166
[TBL] [Abstract][Full Text] [Related]
15. Disruption of Spermatogenesis and Infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2).
Becherel OJ; Fogel BL; Zeitlin SI; Samaratunga H; Greaney J; Homer H; Lavin MF
Cerebellum; 2019 Jun; 18(3):448-456. PubMed ID: 30778901
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel senataxin mutations in Chinese patients with autosomal recessive cerebellar ataxias by targeted next-generation sequencing.
Lu C; Zheng YC; Dong Y; Li HF
BMC Neurol; 2016 Sep; 16(1):179. PubMed ID: 27644330
[TBL] [Abstract][Full Text] [Related]
17. Unique Ataxia-Oculomotor Apraxia 2 (AOA2) in Israel with Novel Variants, Atypical Late Presentation, and Possible Identification of a Poison Exon.
Ponger P; Kurolap A; Lerer I; Dagan J; Chai Gadot C; Mory A; Wilnai Y; Oniashvili N; Giladi N; Gurevich T; Meiner V; Lossos A; Baris Feldman H
J Mol Neurosci; 2022 Aug; 72(8):1715-1723. PubMed ID: 35676594
[TBL] [Abstract][Full Text] [Related]
18. A new SETX mutation producing AOA2 in two siblings.
Datta N; Hohler A
Int J Neurosci; 2013 Sep; 123(9):670-3. PubMed ID: 23566282
[TBL] [Abstract][Full Text] [Related]
19. [Autosomal recessive cerebellar ataxias with oculomotor apraxia].
Le Ber I; Rivaud-Péchoux S; Brice A; Dürr A
Rev Neurol (Paris); 2006 Feb; 162(2):177-84. PubMed ID: 16518257
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Genetic Characterization of Brazilian Patients with Ataxia and Oculomotor Apraxia.
da Costa SCG; Rezende Filho FM; de Freitas JL; de Assis Pereira Matos PCA; Della-Ripa B; França MC; Marques W; Santos M; Cronemberger IVB; Vale TC; Kok F; Alonso I; Pedroso JL; Barsottini OGP
Mov Disord; 2022 Jun; 37(6):1309-1316. PubMed ID: 35426160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
